These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38293235)

  • 1. Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking.
    Johnson EC; Austin-Zimmerman I; Thorpe HH; Levey DF; Baranger DA; Colbert SM; Demontis D; Khokhar JY; Davis LK; Edenberg HJ; Forti MD; Sanchez-Roige S; Gelernter J; Agrawal A
    medRxiv; 2024 Jan; ():. PubMed ID: 38293235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking.
    Johnson EC; Austin-Zimmerman I; Thorpe HHA; Levey DF; Baranger DAA; Colbert SMC; Demontis D; Khokhar JY; Davis LK; Edenberg HJ; Di Forti M; Sanchez-Roige S; Gelernter J; Agrawal A
    Neuropsychopharmacology; 2024 Jun; ():. PubMed ID: 38906991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between cannabis and schizophrenia: a genetically informed perspective.
    Johnson EC; Hatoum AS; Deak JD; Polimanti R; Murray RM; Edenberg HJ; Gelernter J; Di Forti M; Agrawal A
    Addiction; 2021 Nov; 116(11):3227-3234. PubMed ID: 33950550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropy and genetically inferred causality linking multisite chronic pain to substance use disorders.
    Koller D; Friligkou E; Stiltner B; Pathak GA; Løkhammer S; Levey DF; Zhou H; Hatoum AS; Deak JD; Kember RL; Treur JL; Kranzler HR; Johnson EC; Stein MB; Gelernter J; Polimanti R
    Mol Psychiatry; 2024 Feb; ():. PubMed ID: 38355787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic influences and causal pathways shared between cannabis use disorder and other substance use traits.
    Galimberti M; Levey DF; Deak JD; Zhou H; Stein MB; Gelernter J
    Mol Psychiatry; 2024 Apr; ():. PubMed ID: 38580809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed study.
    Cheng W; Parker N; Karadag N; Koch E; Hindley G; Icick R; Shadrin A; O'Connell KS; Bjella T; Bahrami S; Rahman Z; Tesfaye M; Jaholkowski P; Rødevand L; Holen B; Lagerberg TV; Steen NE; Djurovic S; Dale AM; Frei O; Smeland OB; Andreassen OA
    Lancet Psychiatry; 2023 Jun; 10(6):441-451. PubMed ID: 37208114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic correlation, pleiotropy, and causal associations between substance use and psychiatric disorder.
    Jang SK; Saunders G; Liu M; ; Jiang Y; Liu DJ; Vrieze S
    Psychol Med; 2022 Apr; 52(5):968-978. PubMed ID: 32762793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility for schizophrenia after adjustment by genetic susceptibility for smoking: implications in identification of risk genes and genetic correlation with related traits.
    Al-Soufi L; Costas J
    Psychol Med; 2023 Mar; ():1-11. PubMed ID: 36876478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders.
    Koller D; Mitjans M; Kouakou M; Friligkou E; Cabrera-Mendoza B; Deak JD; Llonga N; Pathak GA; Stiltner B; Løkhammer S; Levey DF; Zhou H; Hatoum AS; Kember RL; Kranzler HR; Stein MB; Corominas R; Demontis D; Artigas MS; Ramos-Quiroga JA; Gelernter J; Ribasés M; Cormand B; Polimanti R
    Psychiatry Res; 2024 Mar; 333():115758. PubMed ID: 38335780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.
    Jiang X; Deng Q; Stener-Victorin E
    Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies.
    Munn-Chernoff MA; Johnson EC; Chou YL; Coleman JRI; Thornton LM; Walters RK; Yilmaz Z; Baker JH; Hübel C; Gordon S; Medland SE; Watson HJ; Gaspar HA; Bryois J; Hinney A; Leppä VM; Mattheisen M; Ripke S; Yao S; Giusti-Rodríguez P; Hanscombe KB; Adan RAH; Alfredsson L; Ando T; Andreassen OA; Berrettini WH; Boehm I; Boni C; Boraska Perica V; Buehren K; Burghardt R; Cassina M; Cichon S; Clementi M; Cone RD; Courtet P; Crow S; Crowley JJ; Danner UN; Davis OSP; de Zwaan M; Dedoussis G; Degortes D; DeSocio JE; Dick DM; Dikeos D; Dina C; Dmitrzak-Weglarz M; Docampo E; Duncan LE; Egberts K; Ehrlich S; Escaramís G; Esko T; Estivill X; Farmer A; Favaro A; Fernández-Aranda F; Fichter MM; Fischer K; Föcker M; Foretova L; Forstner AJ; Forzan M; Franklin CS; Gallinger S; Giegling I; Giuranna J; Gonidakis F; Gorwood P; Gratacos Mayora M; Guillaume S; Guo Y; Hakonarson H; Hatzikotoulas K; Hauser J; Hebebrand J; Helder SG; Herms S; Herpertz-Dahlmann B; Herzog W; Huckins LM; Hudson JI; Imgart H; Inoko H; Janout V; Jiménez-Murcia S; Julià A; Kalsi G; Kaminská D; Karhunen L; Karwautz A; Kas MJH; Kennedy JL; Keski-Rahkonen A; Kiezebrink K; Kim YR; Klump KL; Knudsen GPS; La Via MC; Le Hellard S; Levitan RD; Li D; Lilenfeld L; Lin BD; Lissowska J; Luykx J; Magistretti PJ; Maj M; Mannik K; Marsal S; Marshall CR; Mattingsdal M; McDevitt S; McGuffin P; Metspalu A; Meulenbelt I; Micali N; Mitchell K; Monteleone AM; Monteleone P; Nacmias B; Navratilova M; Ntalla I; O'Toole JK; Ophoff RA; Padyukov L; Palotie A; Pantel J; Papezova H; Pinto D; Rabionet R; Raevuori A; Ramoz N; Reichborn-Kjennerud T; Ricca V; Ripatti S; Ritschel F; Roberts M; Rotondo A; Rujescu D; Rybakowski F; Santonastaso P; Scherag A; Scherer SW; Schmidt U; Schork NJ; Schosser A; Seitz J; Slachtova L; Slagboom PE; Slof-Op't Landt MCT; Slopien A; Sorbi S; Świątkowska B; Szatkiewicz JP; Tachmazidou I; Tenconi E; Tortorella A; Tozzi F; Treasure J; Tsitsika A; Tyszkiewicz-Nwafor M; Tziouvas K; van Elburg AA; van Furth EF; Wagner G; Walton E; Widen E; Zeggini E; Zerwas S; Zipfel S; Bergen AW; Boden JM; Brandt H; Crawford S; Halmi KA; Horwood LJ; Johnson C; Kaplan AS; Kaye WH; Mitchell J; Olsen CM; Pearson JF; Pedersen NL; Strober M; Werge T; Whiteman DC; Woodside DB; Grove J; Henders AK; Larsen JT; Parker R; Petersen LV; Jordan J; Kennedy MA; Birgegård A; Lichtenstein P; Norring C; Landén M; Mortensen PB; Polimanti R; McClintick JN; Adkins AE; Aliev F; Bacanu SA; Batzler A; Bertelsen S; Biernacka JM; Bigdeli TB; Chen LS; Clarke TK; Degenhardt F; Docherty AR; Edwards AC; Foo JC; Fox L; Frank J; Hack LM; Hartmann AM; Hartz SM; Heilmann-Heimbach S; Hodgkinson C; Hoffmann P; Hottenga JJ; Konte B; Lahti J; Lahti-Pulkkinen M; Lai D; Ligthart L; Loukola A; Maher BS; Mbarek H; McIntosh AM; McQueen MB; Meyers JL; Milaneschi Y; Palviainen T; Peterson RE; Ryu E; Saccone NL; Salvatore JE; Sanchez-Roige S; Schwandt M; Sherva R; Streit F; Strohmaier J; Thomas N; Wang JC; Webb BT; Wedow R; Wetherill L; Wills AG; Zhou H; Boardman JD; Chen D; Choi DS; Copeland WE; Culverhouse RC; Dahmen N; Degenhardt L; Domingue BW; Frye MA; Gäebel W; Hayward C; Ising M; Keyes M; Kiefer F; Koller G; Kramer J; Kuperman S; Lucae S; Lynskey MT; Maier W; Mann K; Männistö S; Müller-Myhsok B; Murray AD; Nurnberger JI; Preuss U; Räikkönen K; Reynolds MD; Ridinger M; Scherbaum N; Schuckit MA; Soyka M; Treutlein J; Witt SH; Wodarz N; Zill P; Adkins DE; Boomsma DI; Bierut LJ; Brown SA; Bucholz KK; Costello EJ; de Wit H; Diazgranados N; Eriksson JG; Farrer LA; Foroud TM; Gillespie NA; Goate AM; Goldman D; Grucza RA; Hancock DB; Harris KM; Hesselbrock V; Hewitt JK; Hopfer CJ; Iacono WG; Johnson EO; Karpyak VM; Kendler KS; Kranzler HR; Krauter K; Lind PA; McGue M; MacKillop J; Madden PAF; Maes HH; Magnusson PKE; Nelson EC; Nöthen MM; Palmer AA; Penninx BWJH; Porjesz B; Rice JP; Rietschel M; Riley BP; Rose RJ; Shen PH; Silberg J; Stallings MC; Tarter RE; Vanyukov MM; Vrieze S; Wall TL; Whitfield JB; Zhao H; Neale BM; Wade TD; Heath AC; Montgomery GW; Martin NG; Sullivan PF; Kaprio J; Breen G; Gelernter J; Edenberg HJ; Bulik CM; Agrawal A
    Addict Biol; 2021 Jan; 26(1):e12880. PubMed ID: 32064741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci.
    Deak JD; Zhou H; Galimberti M; Levey DF; Wendt FR; Sanchez-Roige S; Hatoum AS; Johnson EC; Nunez YZ; Demontis D; Børglum AD; Rajagopal VM; Jennings MV; Kember RL; Justice AC; Edenberg HJ; Agrawal A; Polimanti R; Kranzler HR; Gelernter J
    Mol Psychiatry; 2022 Oct; 27(10):3970-3979. PubMed ID: 35879402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide identification of the shared genetic basis of cannabis and cigarette smoking and schizophrenia implicates NCAM1 and neuronal abnormality.
    Song W; Lin GN; Yu S; Zhao M
    Psychiatry Res; 2022 Apr; 310():114453. PubMed ID: 35235886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared genetic links between hypothyroidism and psychiatric disorders: evidence from a comprehensive genetic analysis.
    Zhou J; Zhu L
    Front Endocrinol (Lausanne); 2024; 15():1370019. PubMed ID: 38904036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications.
    Levey DF; Galimberti M; Deak JD; Wendt FR; Bhattacharya A; Koller D; Harrington KM; Quaden R; Johnson EC; Gupta P; Biradar M; Lam M; Cooke M; Rajagopal VM; Empke SLL; Zhou H; Nunez YZ; Kranzler HR; Edenberg HJ; Agrawal A; Smoller JW; Lencz T; Hougaard DM; Børglum AD; Demontis D; ; Gaziano JM; Gandal MJ; Polimanti R; Stein MB; Gelernter J
    Nat Genet; 2023 Dec; 55(12):2094-2103. PubMed ID: 37985822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared Genetic Loci Between Schizophrenia and White Blood Cell Counts Suggest Genetically Determined Systemic Immune Abnormalities.
    Steen NE; Rahman Z; Szabo A; Hindley GFL; Parker N; Cheng W; Lin A; O'Connell KS; Sheikh MA; Shadrin A; Bahrami S; Karthikeyan S; Hoseth EZ; Dale AM; Aukrust P; Smeland OB; Ueland T; Frei O; Djurovic S; Andreassen OA
    Schizophr Bull; 2023 Sep; 49(5):1345-1354. PubMed ID: 37319439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Mendelian randomization to explore the gateway hypothesis: possible causal effects of smoking initiation and alcohol consumption on substance use outcomes.
    Reed ZE; Wootton RE; Munafò MR
    Addiction; 2022 Mar; 117(3):741-750. PubMed ID: 34590374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder.
    Johnson EC; Kapoor M; Hatoum AS; Zhou H; Polimanti R; Wendt FR; Walters RK; Lai D; Kember RL; Hartz S; Meyers JL; Peterson RE; Ripke S; Bigdeli TB; Fanous AH; Pato CN; Pato MT; Goate AM; Kranzler HR; O'Donovan MC; Walters JTR; Gelernter J; Edenberg HJ; Agrawal A
    Psychol Med; 2023 Mar; 53(4):1196-1204. PubMed ID: 34231451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocalization of association signals at nicotinic acetylcholine receptor genes between schizophrenia and smoking traits.
    Al-Soufi L; Costas J
    Drug Alcohol Depend; 2021 Mar; 220():108517. PubMed ID: 33454625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterising the shared genetic determinants of bipolar disorder, schizophrenia and risk-taking.
    Hindley G; Bahrami S; Steen NE; O'Connell KS; Frei O; Shadrin A; Bettella F; Rødevand L; Fan CC; Dale AM; Djurovic S; Smeland OB; Andreassen OA
    Transl Psychiatry; 2021 Sep; 11(1):466. PubMed ID: 34497263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.